rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    WST
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      West Pharmaceutical Services (WST) Stock May Be 29% Overvalued On Cash Flow Views

      West Pharmaceutical Services has been on a strong run, and the share price now puts a clear spotlight on one question: Are investors paying a level that its future cash flows can reasonably support, or has the market moved ahead of what the business is likely to generate in hard dollars over time? The stock has returned 54.7% over the past year, which puts real pressure on the cash flow outlook to justify how far the valuation has moved. The business model, built around drug delivery...

      Nov 13Yahoo FinanceWST
      West to Participate in Upcoming Investor Conference
      Nov 4MorningstarWST
      West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors
      Nov 2MarketWatchWST
      Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410
      Nov 2Yahoo FinanceWST
      Jefferies raises West Pharmaceutical stock price target on HVP growth
      Nov 2Investing.comWST
      How Investors Are Reacting To West (WST) Earnings Beat
      Nov 1Yahoo FinanceWST
      West Pharmaceutical Services (WST) Lifted Its Outlook, Is The Stock Fully Priced?
      Nov 1Yahoo FinanceWST
      1 healthcare stock with impressive fundamentals and 2 we ignore

      Detailed price information for Zoetis Inc Cl A (ZTS-N) from The Globe and Mail including charting and trades.

      Nov 1The Globe and MailWST
      What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call
      Oct 31Yahoo FinanceWST
      WST Q3 deep dive: Biologics and regulatory tailwinds fuel margin expansion, HVP mix shift continues

      Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

      Oct 30The Globe and MailWST
      Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating
      Oct 30Yahoo FinanceWST
      West Pharmaceutical Services, Inc. Q3 2026 Earnings Call Summary
      Oct 29Yahoo FinanceWST
      West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
      Oct 29MarketWatchWST
      West Pharma earnings show it's more than a GLP-1 play. Why we see more upside

      Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.

      Oct 29CNBCWST
      West Pharmaceutical Services Inc (WST) (Q3 2026) Earnings Call Highlights: Record Margins, 36% ...
      Oct 29Yahoo FinanceWST
      West Pharmaceutical Q3 2026 slides: margins expand, guidance raised
      Oct 29Investing.comWST
      Earnings call transcript: West Pharmaceutical Services tops Q3 2026 estimates, lifts outlook
      Oct 29Investing.comWST
      West Pharmaceutical Servs Q3 2026 Earnings Call Transcript
      Oct 29BenzingaWST
      Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics

      Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

      Oct 29Yahoo FinanceWST
      West Pharmaceutical's Q3 Adjusted Earnings, Sales Rise; 2026 Outlook Increased
      Oct 29Yahoo FinanceWST
      West Pharmaceutical Services (NYSE:WST) beats expectations in strong Q3 2026, full-year outlook slightly exceeds expectations
      Oct 29BarchartWST
      West Pharmaceutical Services earnings beat by $0.46, revenue topped estimates
      Oct 29Investing.comWST
      West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
      Oct 29Yahoo FinanceWST
      West Pharmaceutical: Q3 Earnings Snapshot
      Oct 29Yahoo FinanceWST
      West Reports Third-Quarter 2026 Results
      Oct 29MorningstarWST
      West (WST) Stock Could Be 28% Overvalued As Cash Flow Falls Short
      Oct 29Yahoo FinanceWST
      West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
      Oct 28MarketWatchWST
      West Pharmaceutical faces earnings test at all-time highs
      Oct 28Investing.comWST
      Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $425 From $440
      Oct 28Yahoo FinanceWST
      West Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
      Oct 28Yahoo FinanceWST
      West Pharmaceutical Services earnings: what to look for from WST
      Oct 28Yahoo FinanceWST
      West Pharmaceutical Services Enhances Liquidity With New Credit Facility

      Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

      Oct 27The Globe and MailWST
      West Pharmaceutical Services stock hits 52-week high at $397.28
      Oct 27Investing.comWST
      WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?

      Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

      Oct 27The Globe and MailWST
      West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
      Oct 21MarketWatchWST
      Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

      Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailWST
      West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
      Oct 20MarketWatchWST
      West Declares Quarterly Dividend
      Oct 19MorningstarWST
      3 Low-Volatility Stocks We’re Skeptical Of

      Detailed price information for Timken Company (TKR-N) from The Globe and Mail including charting and trades.

      Oct 19The Globe and MailWST
      West Pharmaceutical Services stock hits 52-week high at $386.08
      Oct 16Investing.comWST
      West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains
      Oct 15MarketWatchWST
      West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
      Oct 15Yahoo FinanceWST
      Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’ - Meta Platforms (NASDAQ:META)

      CNBC traders picked WST, JPM, META and IYE; analysts raised WST and META targets, while JPM missed Q3 earnings and revenue estimates.

      Oct 14BenzingaJPMWST
      West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
      Oct 13MarketWatchWST
      TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410
      Oct 13Yahoo FinanceWST
      West Pharmaceutical Services Needs Faster Earnings Growth To Justify Its Price (NYSE:WST)

      West Pharmaceutical's sustained premium valuation demands proven earnings and cash flow improvements. See why I rate WST stock a Sell.

      Oct 8Seeking AlphaWST
      West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short

      West Pharmaceutical Services has seen its share price climb sharply in recent periods, and that kind of run naturally raises a question for anyone looking at the stock today: Are the cash flows the business can generate over time enough to support where the market is currently pricing West Pharmaceutical Services? The share price has gained 37.2% over the past year, which puts a lot of weight on whether the underlying cash flows can keep backing up that move. The group’s role in supplying...

      Oct 8Yahoo FinanceWST
      West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors
      Oct 7MarketWatchWST
      West Pharma Stock: Still A Buy, But Expectations Are Rising (NYSE:WST)

      West Pharma (WST) is still a buy: GLP-1 demand, HVP upgrades, and Annex 1 regulatory conversions fuel growth. Read here for a detailed analysis.

      Oct 7Seeking AlphaWST
      West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day
      Oct 6MarketWatchWST

      This is the newest page. Registered accounts read further back.